Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Net of Acquisitions & Divestments (2023)

Updated

Analysis

Moderna (MRNA) Net of Acquisitions & Divestments (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -8.75 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 17.24 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 39.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -11.21 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -85.00 Mn
API Access

Moderna Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=MRNA&period=max&api_key=YOUR_API_KEY